Hypomagnesaemia in kidney transplantation

Area of Science:

• Nephrology
• Transplantation
• Clinical Biochemistry

Background:

• Hypomagnesaemia is frequently observed in kidney transplant recipients, particularly in the early post-transplant period, often linked to calcineurin inhibitor use.
• Low magnesium levels are associated with increased mortality and cardiovascular events in the general population, but this link remains underexplored in transplant patients.

Purpose of the Study:

• To investigate the implications of hypomagnesaemia in kidney transplant recipients.
• To explore the association between magnesium levels and glucose metabolism, diabetes mellitus development, graft function, bone health, and transplant immunology.

Main Methods:

• This study reviews existing literature and observational data concerning hypomagnesaemia in kidney transplant recipients.
• It synthesizes findings from general populations, animal studies, and in vitro research to infer potential impacts.

Main Results:

• Pre- and post-transplant hypomagnesaemia in kidney transplant recipients is linked to aberrant glucose metabolism and a higher incidence of diabetes mellitus.
• Preliminary evidence suggests a potential role for magnesium deficiency in graft dysfunction, bone metabolism, and transplant immunology.

Conclusions:

• Hypomagnesaemia is a significant electrolyte disturbance in kidney transplant recipients with potential systemic consequences.
• Further observational and interventional studies are crucial to establish the benefits of magnesium correction.
• Oral magnesium supplementation alone may be insufficient to normalize serum levels due to renal magnesium wasting.